News & Blog

Latest from the Blog

  1. September 24, 2019

    Defeat Pediatric Brain Tumors Research Collaborative: 2018 Progress Update and 2019 Work in Progress

    The Defeat Pediatric Brain Tumors Research Collaborative has brought together some of the world’s best pediatric brain tumor research teams from St. Jude Children’s Research Hospital, Montreal Children’s Hospital/McGill University Health Centre, and the German Cancer Research Center to work in a team environment and share data and other resources to speed the scientific discovery […]

    Read more | 
  2. September 16, 2019

    Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients?

    Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […]

    Read more | 
  3. September 5, 2019

    Guest Blog: “I would have given anything to trade places with him”

    On a family vacation in 2011, Mac tried to catch a seagull. Using his boogie board to shield his movements, he inched his way across the sand, closing on his target. With the determination and strong-will that defined him, Mac patiently stalked his target for 20 minutes, taking great care with each step as to […]

    Read more | 
Share